Items tagged with Medicines

Global pandemic of fake medicines poses urgent risk, scientists say (post)

Poor quality medicines are a real and urgent threat that could undermine decades of successful efforts to combat HIV/AIDS, malaria and tuberculosis, according to the editors of a collection of journal articles published today. Scientists report up to 41 percent of specimens failed to meet quality standards in global studies of about 17,000 drug samples. Among the collection is an article describing the discovery of falsified and substandard malaria drugs that caused an estimated 122,350 deaths in African children in 2013. Other studies identified poor quality antibiotics, which may harm health and increase antimicrobial resistance. However, new methodologies are being developed to detect problem drugs at the point of purchase and show some promise, scientists say.

WHO reviews its Essential Medicines List; Some new candidates under patent (post)

The World Health Organization is reviewing its list of essential medicines this week. Over 70 candidate medicines are expected to be assessed by an Expert Committee. Some of those medicines are under patent and highly priced, which poses an accessibility challenge.

Locally-sourced drugs effective as internationally quality assured drugs for treating multidrug-resistant TB (post)

Locally-sourced antibiotics can be as effective as ‘internationally quality-assured’ (IQA) antibiotics for treating multidrug-resistant tuberculosis (MDR-TB) in Pakistan, and may help avoid delays in starting treatment while programmes wait for drugs to arrive from overseas, according to new research published in PLOS ONE.  

'Imperfect drug penetration' speeds pathogens' resistance, study finds (post)

SAN FRANCISCO, May 18, 2015 -- Prescribing patients two or more drugs that do not reach the same parts of the body could accelerate a pathogen's resistance to all of the drugs being used in treatment, according to a new study published today in the Proceedings of the National Academy of Sciences.

Children, people with HIV, pregnant women and others underserved by TB drug development present ethical imperative, opportunities for global disease approaches, authors say (post)

Populations with needs that can and do affect the impacts of tuberculosis treatments are among the most vulnerable to the disease, make up significant proportions of the total of people sick with the disease worldwide, but are also the most neglected in TB drug development efforts. An article in a recently released Journal of Infectious Diseases supplement on tuberculosis drug development explores the challenges that developing products of appropriate doses and formulations for children, people with HIV, people with diabetes and pregnant women as well as the opportunities that meeting those challenges present.

What needs to be added to South Africa’s anti-TB toolbox (post)

The approval in South Africa last year of the first new TB drug in 50 years was celebrated as a milestone in the fight against the global epidemic.

New hope in the fight against tuberculosis (post)

Scientists from the HIPS and the HZI discover a new target for the fight against multi-resistant mycobacteria, from a rejuvenated antibiotic series

The next anti-tuberculosis drug may already be in your local pharmacy (post)

07.07.15 - Testing thousands of approved drugs, EPFL scientists have identified an unlikely anti-tuberculosis drug: the over-the-counter antacid lansoprazole (Prevacid®).

MSU scientists set sights on glaucoma medication to treat TB (post)

EAST LANSING, Mich. - A new discovery by Michigan State University scientists suggests that a common medication used to treat glaucoma could also be used to treat tuberculosis, even the drug-resistant kind.

Page 2 of 10 · Total posts: 0

←First 1 2 3 Last→